Sophia Randolph
CIK 1817127 · CHIEF MEDICAL OFFICER · last filed 2024-08-16
Sophia Randolph is a CHIEF MEDICAL OFFICER who has filed 23 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $3.5K of ALXO on Aug 16, 2024. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $514.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$514.6K
1
23
-$4.64M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALXO | CHIEF MEDICAL OFFICER | 325,711 | $1.58 | $514.6K | -$4.64M | 23 | 2024-08-16 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-16 | ALXO | Sell (S) | −1,365 | -$3.5K | EDGAR |
| 2024-07-03 | ALXO | Sell (S) | −3,273 | -$19.0K | EDGAR |
| 2024-05-15 | ALXO | Sell (S) | −12,000 | -$191.3K | EDGAR |
| 2024-02-16 | ALXO | Grant (A) | +30,000 | $0 | EDGAR |
| 2024-01-03 | ALXO | Sell (S) | −3,128 | -$47.0K | EDGAR |
| 2023-07-27 | ALXO | Grant (A) | +34,000 | $0 | EDGAR |
| 2023-07-05 | ALXO | Sell (S) | −1,605 | -$11.8K | EDGAR |
| 2023-06-13 | ALXO | Exer (M) | +12,829 | $48.2K | EDGAR |
| 2023-01-03 | ALXO | Sell (S) | −1,617 | -$17.9K | EDGAR |
| 2022-12-20 | ALXO | Exer (M) | +46,474 | $189.9K | EDGAR |